drugset / Trial / NCT01423838
Comparison of Solifenacin and Oxybutynin in the Treatment of Overactive Bladder
Phase 4
Unknown
500 enrolled
Adana Numune Training and Research Hospital
Akdeniz University · collabAnkara University · collabBaskent University · collabCukurova University · collabGaziosmanpasa University · collabInonu University · collabKahramanmaras Sutcu Imam University · collabKocaeli University · collabUniversity of Gaziantep · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Null hypothesis of the trial is that there is no difference between solifenacin and oxybutynin with respect to efficacy, side effects, patient satisfaction and quality of life measures in patients with overactive bladder.
Timeline
- Start
- 2011-09
- Primary completion
- 2012-09
- Completion
- 2012-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Oxybutynin | Small molecule | 5 mg | Oral |
| Comparator | Solifenacin | Small molecule | 5 mg | Oral |